Paper Details
- Home
- Paper Details
Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder.
Author: CiezkiKristin, JacobsonMegan, SharmaTarun, SighMaharaj, UlteigCrista
Original Abstract of the Article :
Opioid effects on lower gastrointestinal motility are well documented, and increasing attention is being paid to their effect on esophageal motility. Naloxegol is a µ-opioid receptor antagonist that is used for opioid-induced constipation, but its impact on esophageal motility has not been well docu...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791044/
データ提供:米国国立医学図書館(NLM)
Naloxegol: A Potential Solution for Opioid-Induced Esophageal Motility Disorder
Opioids are commonly used for pain relief, but they can have significant side effects on gastrointestinal motility. This case series explores the potential of naloxegol, a medication for opioid-induced constipation, to also improve esophageal motility in patients experiencing dysmotility related to opioid use.
Naloxegol: A Promising Solution for Opioid-Related Motility Problems
This case series suggests that naloxegol may offer a potential solution for patients experiencing opioid-induced esophageal dysmotility. The authors observed improvements in both constipation and esophageal symptoms after starting naloxegol. It's like finding a hidden oasis in the desert of opioid-related gastrointestinal problems, offering a potential solution for a complex and often debilitating condition.
Understanding Opioid Side Effects: A Journey of Gastrointestinal Health
This research highlights the importance of understanding the complex interplay between opioids and gastrointestinal motility. It encourages further investigation into the potential benefits of naloxegol in addressing opioid-induced esophageal dysmotility, potentially improving the quality of life for patients experiencing these challenging side effects. It's like exploring a new frontier in gastrointestinal health, seeking to understand the mechanisms by which opioids affect motility and to discover effective interventions for these problems.
Dr.Camel's Conclusion
This case series offers a promising glimpse into the potential of naloxegol for treating opioid-induced esophageal dysmotility. It underscores the need for further research to investigate this promising treatment option, potentially leading to improved outcomes for patients experiencing these debilitating side effects. It's like finding a new path through the desert of opioid-related gastrointestinal problems, offering hope for a smoother and more comfortable journey.
Date :
- Date Completed n.d.
- Date Revised 2022-02-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.